Retail Trade and Distribution

The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on

The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on

Alibaba's troubles reveal multiple gaps in online enforcement in China

The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline

The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline

China's efforts to crack down on misleading, fraudulent claims forces an industry rethink as they overturn the effects of years of aggressive marketing. The new law regulates content, target audiences and specific industries like tobacco and healthcare, and will increase compliance costs for consumer-oriented businesses

Increased transparency in government procurement.

Foreign investment catalogue revised to allow more foreign shareholding.

Pharmaceutical manufacturers and distributors no longer need a pharmaceutical licence before getting a business licence.